Cargando…
Combination Therapy with CCBs and RAS Inhibitors to Counteract Endothelial Dysfunction in COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929462/ https://www.ncbi.nlm.nih.gov/pubmed/35301707 http://dx.doi.org/10.1007/s40292-022-00515-8 |
| _version_ | 1784670865859805184 |
|---|---|
| author | Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad |
| author_facet | Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad |
| author_sort | Kow, Chia Siang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8929462 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89294622022-03-18 Combination Therapy with CCBs and RAS Inhibitors to Counteract Endothelial Dysfunction in COVID-19 Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad High Blood Press Cardiovasc Prev Letter to the Editor Springer International Publishing 2022-03-17 2022 /pmc/articles/PMC8929462/ /pubmed/35301707 http://dx.doi.org/10.1007/s40292-022-00515-8 Text en © Italian Society of Hypertension 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Kow, Chia Siang Ramachandram, Dinesh Sangarran Hasan, Syed Shahzad Combination Therapy with CCBs and RAS Inhibitors to Counteract Endothelial Dysfunction in COVID-19 |
| title | Combination Therapy with CCBs and RAS Inhibitors to Counteract Endothelial Dysfunction in COVID-19 |
| title_full | Combination Therapy with CCBs and RAS Inhibitors to Counteract Endothelial Dysfunction in COVID-19 |
| title_fullStr | Combination Therapy with CCBs and RAS Inhibitors to Counteract Endothelial Dysfunction in COVID-19 |
| title_full_unstemmed | Combination Therapy with CCBs and RAS Inhibitors to Counteract Endothelial Dysfunction in COVID-19 |
| title_short | Combination Therapy with CCBs and RAS Inhibitors to Counteract Endothelial Dysfunction in COVID-19 |
| title_sort | combination therapy with ccbs and ras inhibitors to counteract endothelial dysfunction in covid-19 |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929462/ https://www.ncbi.nlm.nih.gov/pubmed/35301707 http://dx.doi.org/10.1007/s40292-022-00515-8 |
| work_keys_str_mv | AT kowchiasiang combinationtherapywithccbsandrasinhibitorstocounteractendothelialdysfunctionincovid19 AT ramachandramdineshsangarran combinationtherapywithccbsandrasinhibitorstocounteractendothelialdysfunctionincovid19 AT hasansyedshahzad combinationtherapywithccbsandrasinhibitorstocounteractendothelialdysfunctionincovid19 |